Syngene International Ltd.

727.50 -3.25 ▼-0.4%

27 February 2024, 03:32:18 PM
Volume: 608,761

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.syngeneintl.com
Market Cap 29,286.79 Cr.
Enterprise Value(EV) 28,962.97 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 12.44 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 58.56 Trailing Twelve Months Ending 2023-12
Industry PE 41.67 Trailing Twelve Months Ending 2023-12
Book Value / Share 99.56 Trailing Twelve Months Ending 2023-12
Price to Book Value 7.32 Calculated using Price: 728.50
Dividend Yield 0.17 Period Ending 2023-03
No. of Shares Subscribed 40.20 Cr. 402,015,000 Shares
FaceValue 10
About Syngene International Ltd.
The company is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide. Services offered by the company are Discovery Chemistry, Discovery Biology, Safety Assessment, Large Molecule Development, Chemical Development, Formulation Development, Stability Studies, Polymer Research, Integrated Discovery & Development, Clinical Development Services, Bioinformatics, Antibody Drug Conjugates, Oligonucleotide Synthesis.

Syngene International Ltd. Delivery

Delivered Qty
Traded Qty

Syngene International Ltd. Performance

1 Day
-0.44%
1 Week
-4.68%
1 Month
+6.16%
3 Month
-2.42%
6 Month
-5.07%
1 Year
+28.43%
2 Year
+34.13%
5 Year
+149.49%
10 Year

Syngene International Ltd. Fundamental Ratios

6 years 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 18.05 18.26 20.21 16.59 13.29 13.73
Return on Capital Employed (%) 15.76 16.98 19.6 15.4 13.24 15.43
Return on Assets (%) 9.8 9.86 10.77 9.17 7.69 8.25

Syngene International Ltd. Balance Sheet

Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 1,720 1,968 2,176 2,821 3,298 3,618 3,891
Non Curr. Liab. 613 515 325 840 972 955 681
Curr. Liab. 784 1,129 1,539 1,133 1,229 1,188 1,226
Minority Int.
Equity & Liab. 3,117 3,612 4,040 4,794 5,498 5,761 5,798
Non Curr. Assets 1,396 1,848 2,428 2,987 3,292 3,336 3,423
Curr. Assets 1,720 1,764 1,613 1,807 2,206 2,425 2,375
Misc. Exp. not W/O
Total Assets 3,117 3,612 4,040 4,794 5,498 5,761 5,798

Syngene International Ltd. Profit and Loss

Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 1,423 1,826 2,012 2,184 2,604 3,193 3,566
Other Income 136 76 96 83 108 73 97
Total Income 1,559 1,902 2,108 2,268 2,713 3,266 3,663
Total Expenditure -1,033 -1,290 -1,409 -1,531 -1,864 -2,260 -2,555
PBIDT 527 612 700 736 849 1,005 1,109
Interest -23 -32 -35 -28 -24 -45 -45
Depreciation -131 -164 -219 -275 -310 -367 -410
Taxation -67 -84 -105 -64 -89 -129 -143
Exceptional Items 71 35 -31 -11
PAT 305 332 412 405 396 464 500
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 305 332 412 405 396 464 500
Adjusted EPS 8 8 10 10 10 12 12

Syngene International Ltd. Cash Flow

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 446 630 677 701 581 824
Cash Fr. Inv. -349 -647 -428 -628 -612 -656
Cash Fr. Finan. -79 -72 -226 58 -31 -343
Net Change 18 -89 23 131 -62 -175
Cash & Cash Eqvt 253 165 193 323 262 90

Syngene International Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 70.41 70.41 70.29 64.86 64.86 54.88 54.80 54.79 54.79
Public 29.59 29.59 29.71 35.14 35.14 45.12 45.20 45.20 45.21
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Syngene International Ltd. Announcements

Mon, 26 Feb 2024
Updates
Syngene International Limited has informed the Exchange regarding the Cancellation of Meeting with the Analyst/Institutional Investor.
Sun, 25 Feb 2024
Updates
Syngene International Limited has informed the Exchange regarding the cancellation of the Analyst/Institutional Investor meetings.
Fri, 23 Feb 2024
Analysts/Institutional Investor Meet/Con. Call Updates
Syngene International Limited has informed the Exchange about Schedule Of Analyst/Institutional Investor Meeting

Syngene International Ltd. Technical Scans

Mon, 26 Feb 2024
Close Crossing Last Week Low Close Crossing Last Week Low
Closing Below Previous Low Closing Below Previous Low
Close Below Last Week Low Close Below Last Week Low
High Increase in 1 Month High Increase in 1 Month
High Increase in 5 Years High Increase in 5 Years

Syngene International Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 373,564.46 1,582.75 +1.7%
Cipla Ltd. 118,662.53 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. 107,402.65 6,449.60 +0.1%
Zydus Lifesciences Ltd. 95,410.36 942.85 +0.0%
Divi's Laboratories Ltd. 94,984.66 3,539.80 -1.0%
Apollo Hospitals Enterprise Ltd. 94,585.14 6,620.60 +0.6%
Torrent Pharmaceuticals Ltd. 88,769.16 2,625.95 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.94 1,582.75 +1.7%
Cipla Ltd. Consolidated 2023-12 32.00 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.54 6,449.60 +0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.08 942.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 68.68 3,539.80 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 119.83 6,620.60 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.42 2,625.95 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.99 1,582.75 +1.7%
Cipla Ltd. Consolidated 2023-12 4.58 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,449.60 +0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.91 942.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.29 3,539.80 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.00 6,620.60 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.41 2,625.95 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,582.75 +1.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,449.60 +0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 942.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,539.80 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,620.60 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,625.95 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,582.75 +1.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,449.60 +0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 942.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,539.80 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,620.60 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,625.95 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,582.75 +1.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,449.60 +0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 942.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,539.80 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,620.60 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,625.95 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,582.75 +1.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,449.60 +0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 942.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,539.80 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,620.60 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,625.95 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,582.75 +1.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,449.60 +0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 942.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,539.80 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,620.60 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,625.95 +0.1%

Syngene International Ltd. FAQ's

What is Syngene Internation. share price?

Can I buy Syngene Internation. shares now?

What is the Dividend Yield of Syngene Internation.?

What is the Market Cap of Syngene Internation.?

What are the key metrics to analyse Syngene Internation.?

What is the 52 Week High and Low of Syngene Internation.?

What is the trend of Syngene Internation. share price?